SOYDAL, Ç. Et Al. 2014. The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE. Annual Congress of the European Association of Nuclear Medicine , 225.

SOYDAL, Ç., PEKER, A., ÖZKAN, E., KÜÇÜK, N. Ö., & KIR, K. M., (2014). The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE . Annual Congress of the European Association of Nuclear Medicine (pp.225).

SOYDAL, ÇİĞDEM Et Al. "The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE," Annual Congress of the European Association of Nuclear Medicine, 2014

SOYDAL, ÇİĞDEM Et Al. "The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE." Annual Congress of the European Association of Nuclear Medicine , pp.225, 2014

SOYDAL, Ç. Et Al. (2014) . "The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE." Annual Congress of the European Association of Nuclear Medicine , p.225.

@conferencepaper{conferencepaper, author={ÇİĞDEM SOYDAL Et Al. }, title={The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of respon8se to fixed dose peptide receptor radionuclide therapy with Lu-177 DOTATATE}, congress name={Annual Congress of the European Association of Nuclear Medicine}, city={}, country={}, year={2014}, pages={225} }